Markers of metastatic carcinoma of breast origin
Author:
Affiliation:
1. PhenoPath Laboratories; Seattle WA USA
2. Pacific Pathology Partners; Seattle WA USA
Publisher
Wiley
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12877/fullpdf
Reference58 articles.
1. Cancer of unknown primary site;Pavlidis;Lancet,2012
2. International variation in female breast cancer incidence and mortality rates;DeSantis;Cancer Epidemiol. Biomarkers Prev.,2015
3. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study;Elledge;Int. J. Cancer,2000
4. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J. Clin. Oncol.,1999
5. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions;Kawabata;Mod. Pathol.,2003
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gastric Metastasis Mimicking Early Gastric Cancer from Invasive Ductal Carcinoma of the Breast: Case Report and Literature Review;Medicina;2024-06-13
2. Breast cancer with biomarker reversal during the course of treatment: a case report;Journal of Surgical Case Reports;2024-06
3. Case report: Cutaneous metastases as a first manifestation from breast cancer with concurrent gastric metastases;Frontiers in Pharmacology;2024-03-04
4. Cancer‐related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report;Cancer Reports;2024-03
5. Thyroid Metastases from Triple-Negative Breast Cancer with High PD-L1 Expression – A Rare Presentation;OncoTargets and Therapy;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3